Neuropace, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
5.88
|
|
Average Rating
|
3.25
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.47
|
0.00
|
0.47
|
100.00%
|
|
2022-12-31
|
-0.51
|
0.00
|
0.51
|
100.00%
|
|
2022-09-30
|
-0.53
|
-0.48
|
0.05
|
9.43%
|
|
2022-06-30
|
-0.44
|
-0.52
|
-0.08
|
-18.18%
|
|
2022-03-31
|
-0.44
|
-0.47
|
-0.03
|
-6.82%
|
|
2021-12-31
|
-0.33
|
-0.44
|
-0.11
|
-33.33%
|
|
2021-09-30
|
-0.30
|
-0.34
|
-0.04
|
-13.33%
|
|
2021-06-30
|
-0.34
|
-0.48
|
-0.14
|
-41.18%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.47
|
|
2021-12-31
|
-33.99
|
|
2020-12-31
|
-0.17
|